Actavis cannot drop old version of Alzheimer's drug - appeals court
May 22, 2015 at 10:51 AM EDT
NEW YORK, May 22 (Reuters) - Actavis Plc cannot pull its top-selling Alzheimer's drug from the market in favor of a pricier extended-release version, a federal appeals court ruled on Friday.
